Работы, на которые ссылается эта работа

Работ: 37

Работа: Design of Tripeptides as a Competitive Inhibitor for HMG-CoA Reductase

1. Syrian Hamster 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Expressed in Escherichia coli: Production of Homogeneous Protein

   Kenneth Frimpong, Bryant G. Darnay, V.W. Rodwell

   Статья1993Цитирований: 4

   ABIABI:AkademIndex/openalex/2026.other.379531

2. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes

   F. William Studier, Barbara A. Moffatt

   Статья1986Цитирований: 4

   ABIABI:AkademIndex/openalex/2026.other.379532

3. Biomedical applications of dipeptides and tripeptides

   Sara Santos, Inês M. Torcato, Miguel A. R. B. Castanho

   Обзорная статья2012Цитирований: 4

   ABIABI:AkademIndex/openalex/2026.other.379535

4. Structure-Based Drug Design: Docking and Scoring

   Romano T. Kroemer

   Обзорная статья2007Цитирований: 4

   ABIABI:AkademIndex/openalex/2026.other.379536

5. The Natural Products as Hydroxymethylglutaryl-Coa Reductase Inhibitors

   Hayrettin Ozan Gülcan, Serkan Yiğitkan, İlkay Erdoğan Orhan

   Статья2018Цитирований: 4

   ABIABI:AkademIndex/openalex/2026.other.379539

6. Inhibitor design for <scp>3‐hydroxy‐3‐methyl‐glutaryl‐CoA</scp> reductase enzyme; molecular docking and determination of molecular and electronic properties of ligands by density functional theory method

   Selami Ercan, Ercan Çınar, Cihat Özaydın +2

   Статья2020Цитирований: 4

   ABIABI:AkademIndex/openalex/2026.other.379541

7. Low High-Density Lipoprotein Cholesterol and Increased Cardiovascular Disease Risk: An Analysis of Statin Clinical Trials

   Prakash Deedwania, Vibhuti Singh, Michael H. Davidson

   Статья2009Цитирований: 3

   ABIABI:AkademIndex/openalex/2026.other.056704

8. Hypercholesterolemia As a Risk Factor for Cardiovascular Disease: Current Controversial Therapeutic Management

   Arturo Zárate, Leticia Manuel‐Apolinar, Renata Saucedo +2

   Обзорная статья2016Цитирований: 3

   ABIABI:AkademIndex/openalex/2026.other.379537

9. Molecular aspects of hypercholesterolemia treatment: current perspectives and hopes

   Najmeh Ahangari, Majid Ghayour‐Mobarhan, Amirhossein Sahebkar +1

   Обзорная статья2018Цитирований: 3

   ABIABI:AkademIndex/openalex/2026.other.379538

10. Incidence of Cardiovascular Disease in Patients with Familial Hypercholesterolemia Phenotype: Analysis of 5 Years Follow-Up of Real-World Data from More than 1.5 Million Patients

    L. Masana, Alberto Zamora, Núria Plana +9

    Статья2019Цитирований: 3

    ABIABI:AkademIndex/openalex/2026.other.379540

11. Cholesterol Lowering With Statin Drugs, Risk of Stroke, and Total Mortality

    Patricia R. Hebert, J. Michael Gaziano, Ki Sau Chan +1

    Статья1998Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.379530

12. Без названия

    ДругоеЦитирований: 1

    ABIABI:AkademIndex/openalex/2026.other.379534